OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
31 hedge funds and large institutions have $27.4M invested in OncoSec Medical Incorporated in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 3 closing their positions.
606% more capital invested
Capital invested by funds: $3.89M → $27.4M (+$23.6M)
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
24% more funds holding
Funds holding: 25 → 31 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$9.46M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$2.53M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$380K |
| 5 |
Two Sigma Investments
New York
|
+$226K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$406K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$55.8K |
| 3 |
VF
Virtu Financial
New York
|
-$34K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$27.4K |
| 5 |
SM
Salzhauer Michael
|
-$24.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $19K | -$12.2K | -114 | -46% |
|
|
DWA
27
Dorsey Wright & Associates
Pasadena,
California
| $14K | +$10.5K | +98 | New |
|
|
SFS
28
Sowell Financial Services
North Little Rock,
Arkansas
| $5K | +$3.63K | +34 | New |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$320 | +3 | +19% |
|
30
Bank of America
Charlotte,
North Carolina
| $1K | -$107 | -1 | -13% |
|
31
Wells Fargo
San Francisco,
California
| $1K | +$107 | +1 | +33% |
|
|
VF
32
Virtu Financial
New York
| – | -$34K | -462 | Closed |
|
|
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$16.9K | -227 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$15K | -202 | Closed |
|
ONCS Hedge Fund Activity: Q4 2020 in Review
31 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2020, worth a combined $27.4M — up 606% from $3.89M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ONCS positions and 3 closed out — a net gain of 6 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $9.46M. The largest seller was Renaissance Technologies, cutting an estimated $406K.
- 31 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2020, up from 25 in Q3 2020.
- Funds reported $27.4M of OncoSec Medical Incorporated stock for Q4 2020, up 606% quarter-over-quarter.
- 9 funds opened new OncoSec Medical Incorporated positions in Q4 2020 and 3 closed out, a net change of +6 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2020 was Avidity Partners Management, an estimated $9.46M added.
- The largest OncoSec Medical Incorporated seller in Q4 2020 was Renaissance Technologies, an estimated $406K sold.
Based on aggregated 13F filings for Q4 2020.